Download FREE Report Sample
Download Free sampleZolpipram generally refers to sinosi (zolpipram tartrate tablets), indications for this product is limited for the treatment of occasional insomnia, temporary insomnia serious sleep disorders.
Zolpipram Market contains market size and forecasts of Zolpipram in Global, including the following market information:
Global Zolpipram Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Zolpipram market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Sublingual Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Zolpipram include Sanofi, Hikma Pharmaceuticals, Northstar Rx, Teva Pharmaceuticals, Torrent Pharma, Apotex, Endo, Mylan Pharmaceuticals and Synthelabo Groupe, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Zolpipram companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Zolpipram Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Zolpipram Market Segment Percentages, by Type, 2021 (%)
Sublingual Tablets
Oral Spray
Global Zolpipram Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Zolpipram Market Segment Percentages, by Application, 2021 (%)
Sporadic Insomnia
Temporary Insomnia
Global Zolpipram Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Zolpipram Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Zolpipram revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Zolpipram revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Hikma Pharmaceuticals
Northstar Rx
Teva Pharmaceuticals
Torrent Pharma
Apotex
Endo
Mylan Pharmaceuticals
Synthelabo Groupe
Hu'nan Qianjin Xiangjiang Pharmaceutical
Jiangsu Haosen Pharmaceutical Group
Shanxi Quantum hi-tech Pharmaceutical
Shanghai Shyndec Pharmaceutical
Lunan Pharmaceutical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy